Loading...

DWTX DOGWOOD THERAPEUTICS INC Management Changes 8-K Filing

DGWD

DWTX

DOGWOOD THERAPEUTICS INC

(DWTX)

2025 8-K

Equity Distribution Agreement

Equity Plan Approval

Q3 Earnings Report

Investor Presentation

Licensing Agreement Signed

Financial Results Announced

Compensatory Arrangements o...

Equity Offerings

Financial Statements

Compliance Update

Financial Results

Company Acquisition

Quarterly Results

Nasdaq Compliance

Business Combination

Financial Results Announcement

Annual Meeting Results

Public Offering

Results of Operations

Meeting Approval

Financial Results Announcement

Salary Reduction and Stock ...

Letter to Shareholders

Financial Results Announcement

Regulation FD Disclosure

Termination of Sales Agreement

Financial Results Announcement

FDA Review of Chronic Toxic...

Results of Operations and F...

Annual Meeting Results

Compliance regained with Na...

Earnings Reports

Compliance Extension

Corporate Progress Report

Financial Results Announcement

External Links:

On June 27, 2025, Dogwood Therapeutics approved a salary increase for CFO Angela Walsh from $279,916 to $321,903 per year, effective July 1, 2025.

AI Assistant

DOGWOOD THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.